TCL Archive In Brief: ‘WSJ” Articles Call Attention To Problems With Cancer Program Knipmeyer to Leave NCI May 19, 1989
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive Senate Subcommittee Oks $850Million for Cancer; NCI Reveals How It Would Spend Fiscal 1978 Funds June 18, 1976
